AGM/EGMApr 26, 2026, 05:31 AM
ADPT 2026 AGM Set for June 5; Elects Directors, Reviews 2025 Results
AI Summary
Adaptive Biotechnologies Corp announced its 2026 Annual Meeting of Shareholders will be held virtually on June 5, 2026. Key proposals include the election of two Class I directors, an advisory vote on 2025 executive compensation, and the ratification of Ernst & Young LLP as the independent auditor for 2026. The company also highlighted strong 2025 financial performance, with revenue increasing to $277.0 million and a significant reduction in net cash used in operations.
Key Highlights
- 2026 Annual Meeting of Shareholders to be held virtually on June 5, 2026.
- Shareholders to elect two Class I directors: Robert Hershberg, PhD, MD and Katey Owen, PhD.
- Advisory vote on 2025 named executive officer compensation.
- Ratification of Ernst & Young LLP as independent auditor for 2026.
- 2025 Revenue: $277.0M, up 54.7% from $179.0M in 2024.
- 2025 Net cash used in operations: $46.0M, a 52% reduction from $95.2M in 2024.
- 2025 MRD revenue: $212.3M, representing 46% growth from 2024.
- Cash, cash equivalents, and marketable securities: $227.2M as of December 31, 2025.